Cited by 721Metabolism, Diabetes, and CancerDiabetes Treatment and ManagementNatural Antidiabetic Agents Studies

The DOI matches its Crossref record; 258 of the 261 references it cites were found in a registry or an index.

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

Open access

Foretz, Marc, Guigas, Bruno, Viollet, Benoit·2019·Nature Reviews Endocrinology

Open this paper in CoChat — free account

Abstract

Despite its position as the first-line drug for treatment of type 2 diabetes mellitus, the mechanisms underlying the plasma glucose level-lowering effects of metformin (1,1-dimethylbiguanide) still remain incompletely understood. Metformin is thought to exert its primary antidiabetic action through the suppression of hepatic glucose production. In addition, the discovery that metformin inhibits the mitochondrial respiratory chain complex 1 has placed energy metabolism and activation of AMP-activated protein kinase (AMPK) at the centre of its proposed mechanism of action. However, the role of AMPK has been challenged and might only account for indirect changes in hepatic insulin sensitivity. Various mechanisms involving alterations in cellular energy charge, AMP-mediated inhibition of adenylate cyclase or fructose-1,6-bisphosphatase 1 and modulation of the cellular redox state through direct inhibition of mitochondrial glycerol-3-phosphate dehydrogenase have been proposed for the acute inhibition of gluconeogenesis by metformin. Emerging evidence suggests that metformin could improve obesity-induced meta-inflammation via direct and indirect effects on tissue-resident immune cells in metabolic organs (that is, adipose tissue, the gastrointestinal tract and the liver). Furthermore, the gastrointestinal tract also has a major role in metformin action through modulation of glucose-lowering hormone glucagon-like peptide 1 and the intestinal bile acid pool and alterations in gut microbiota composition.

Integrity signals

Registry

Crossref · 10.1038/s41574-019-0242-2

Cites

258 of 258 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,659
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
(1998) · PubMed · Cited by 4,290
Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the american diabetes association (ADA) and the european association for the study of diabetes (EASD)
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829

Show all 261 references

Sorted by citations

Items 601–700 of 721

Structural Model of Quality of Life Based on Early Maladaptive Schemas and the Mediating Role of Self-Care in Women with Type 2 Diabetes
Hosseinzadeh, F. S., Sharifirad, G., & Monirpour, N. (2024) · doi:10.61838/kman.aftj.5.4.14
Pyruvate kinase allostery resist hyperglycemia, obesity and inflammation by inducing TCA vortex and glucose U turnPreprint
Zhang, X., Jiang, X., Wu, X., Yang, Y., Wang, J., Zheng, J., Zhou, M., & Chen, Q. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.09.607407
The role of ATP synthase subunit e (ATP5I) in mediating the metabolic and antiproliferative effects of metformin in cancer cells
Lefrançois, G., Lavallée, E., Rowell, M., Bourdeau, V., Mohebali, F., Bertomeu, T., Duman, A. M., Nikolova, M., Tyers, M., Gravel, S., et al. (2024) · eLife · doi:10.7554/elife.102680
Estrategia terapéutica en el paciente diabético (II). Tratamiento farmacológico del paciente con diabetes mellitus tipo 2. Criterios de selección y evidencia actual de los fármacos antidiabéticos no insulínicos
Silva, J. B. Q., Cebada, A. B., Escobar-Morreale, H. F., & Chávez, L. N. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.10.011
Autoimmune Connective Tissue Disorders in Diabetic Patients
Caraiola, S., & Ionescu, R. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-65300-1_24
The Efficacy of Imeglimin Compared to Metformin in Dual Therapy with DPP-4 Inhibitor on Glycemic Control and Weight Management: A Randomized Controlled TrialPreprint
Venkatesan, D., Chandrasekaran, A., Ramalingam, D., Vijayakumar, S., Ananthathandavan, P., & Kumar, J. S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5012893
Overcoming chemotherapy resistance in colorectal cancer
Demetriou, D., Molefi, T., Chatziioannou, A. A., & Dlamini, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-33475-7.00012-3
Short‐term efficacy and safety of metformin in individuals with type 2 diabetes and mild hepatic impairment: A propensity score‐matched real‐world study
Baek, S., Park, J., Chung, J., Kwak, S. H., & Yoon, S. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16108
Reviewer #2 (Public review): The Role of ATP Synthase Subunit e (ATP5I) in Mediating the Metabolic and Antiproliferative Effects of Biguanides
(2024) · eLife · doi:10.7554/elife.102680.1.sa2
The Role of ATP Synthase Subunit e (ATP5I) in Mediating the Metabolic and Antiproliferative Effects of BiguanidesPreprint
Lefrançois, G., Lavallée, E., Rowell, M., Bourdeau, V., Mohebali, F., Bertomeu, T., Tyers, M., Gravel, S., Schmitzer, A. R., & Ferbeyre, G. (2024) · eLife · doi:10.7554/elife.102680.1
O papel da ativação da via AMP-Activated Protein Kinase (AMPK) na modulação metabólica de pacientes diabéticos: uma revisão integrativa
Silva, C. E. L., Cabanha, R. S. D. C. F., Pauperio, C. O. V., SPROCATI, E. A., Rocha, E. A., Girardi, G. A., Guimarães, N. T., & Mendonça, F. C. (2025) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv17n1-099
Clenbuterol and metformin ameliorate cachexia parameters, but only clenbuterol reduces tumor growth via lipid peroxidation in Walker 256 tumor-bearing rats
Henschel, L. D. V., de Lima, M. E. R., Fagundes, F. E. S., Horlem, T., Zazula, M. F., Naliwaiko, K., & Fernandes, L. C. (2025) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2024e14060
Reversal of metformin’s anti-proliferative effect in fission yeast efr3 and dnm1 (DRP1) mutants with elongated mitochondria
Gillespie, A., Mehdorn, A., Lim, T. Q., Wang, T., Mooney, B. A., Ovens, A. J., Orang, A., Oakhill, J. S., Michael, M., & Petersen, J. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00048-9
Vitamin D Status Determines Metformin Action on Gonadotropin Levels in Postmenopausal Women with Subclinical Hyperthyroidism
Krysiak, R. G., Kowalcze, K. E., Szkróbka, W., & Okopień, B. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040442
Metformina/sitagliptina y el efecto sobre la función renal en pacientes con diabetes mellitus tipo 2
Muñoz-Altamirano, G., Cortés, G. M., Medina, G., Escudero-Hernández, L., & Gómez‐García, A. (2025) · Acta Médica Costarricense · doi:10.51481/amc.v66i3.1389
Metformin and Amoxicillin/Clavulanate as Co-Administration for the Treatment of Hyperglycemia in Female Rats Caused by Alloxan.
Al-Gorany, S. M. (2025) · Mağallaẗ ʻulūm al-rāfidayn · doi:10.33899/rjs.2025.187744
THERAPEUTIC EFFECT OF PULAI BARK EXTRACT (Alstonia scholaris L. R. Br) ON BODY WEIGHT OF STREPTOZOTOCIN-INDUCED MICE (Mus musculus)
Assagaf, A. R., & Tarigan, U. K. (2025) · Biofaal Journal · doi:10.30598/biofaal.v6i1pp29-38
Novel Therapies: Pharmacological Approaches to Modulate the Gut Microbiome in Metabolic Syndrome
Gunjan, & Vidić, J. (2025) · Springer eBooks · doi:10.1007/978-981-96-6246-3_5
Identification of Secondary Metabolite Compounds from Porphyra sp Extract and Their Potential as Antidiabetic Agents
UKRATALO, A. M., Buranga, E., Ichsan, M. N., Kaihena, M., & Eddy, L. (2025) · Futurity Medicine. · doi:10.57125/fem.2025.03.30.05
Diabete mellito e sarcopenia
Orsi, E., Arosio, B., Gaglio, A., Resi, V., Locatelli, E., & Volpato, S. (2025) · il Diabete · doi:10.30682/ildia2502a
Comparison of Empagliflozin Versus Vildagliptin in Combination with Metformin in Individuals Diagnosed with Type II Diabetes Mellitus
Haroon, T., Jabeen, M., Maqsood, R., Baig, W. A., Shahab, Z., & Rafique, T. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i7.2091
A Rare Case of Drug-Induced Liver Injury Due to Metformin and Literature Review
刘, 清. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1592514
Decaffeinated Green Tea and Green Coffee Extract Attenuate Cardiac Perivascular Fibrosis in a Metabolic Syndrome Model by Decreasing Fibroblast Growth Factor 23 and Runt-related transcription factor 2 Expression
Rohman, M. S., Hose, V. A. G., & Nugrahenny, D. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i9.53
Food-Drug Interactions: Navigating the Complex Relationship
Ewis, D. K., & El-Sayed, O. S. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-1983-5_14
A Critical Review on Diabetes Mellitus Type 1 and Type 2 Management Approaches: From Lifestyle Modification to Current and Novel Targets and Therapeutic Agents
Pawar, A. D., Rohile, S. B., & D., P. S. S. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-29628
Evaluation of the pharmacological interaction between the hydroalcoholic extract of Blechnum asplenioides “cuti cuti” and metformin in hyperglycemic albino rats
Huaccho-Rojas, J., Hernández, T., Garay, G., & Lens-Sardón, L. (2025) · Revista de la Facultad de Medicina Humana · doi:10.25176/rfmh.v25i3.7357
Impact of immediate-release versus extended-release metformin on lipid profile and body measurements in saudi patients with type 2 diabetes: a prospective cohort study
Alshadfan, H., Mirghani, H. O., Alrasheed, T., Alanazi, M. A., & Abdullah, M. N. H. (2025) · Pan African Medical Journal · doi:10.11604/pamj.2025.52.176.49165
Additional file 1 of Artichoke (Cynara scolymus L.) water extract alleviates palmitate-induced insulin resistance in HepG2 hepatocytes via the activation of IRS1/PI3K/AKT/FoxO1 and GSK-3β signaling pathway
Deng, A., Wang, Y., Huang, K., Xie, P., Mo, P., Liu, F., Chen, J., Chen, K., & Xiao, B. (2023) · Figshare · doi:10.6084/m9.figshare.24844678
Additional file 5 of Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum
Wang, Y., Yu, F., Zheng, X., Li, J., Zhang, Z., Zhang, Q., Chen, J., He, Y., Yang, H., & Zhou, P. (2023) · Figshare · doi:10.6084/m9.figshare.23908883
Chronic life-cycle studies with the priority pharmaceutical metformin: molecular and biochemical assessment with Danio rerio
Ribeiro, M. D. C. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/gs1c-8s18
Additional file 3 of Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway
Zhang, Y.-L., Liu, F., Li, Z.-B., He, X.-T., Li, X., Wu, R.-X., Sun, H.-H., Ge, S.-H., Chen, F.-M., & An, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20329581
Additional file 2 of Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum
Wang, Y., Yu, F., Zheng, X., Li, J., Zhang, Z., Zhang, Q., Chen, J., He, Y., Yang, H., & Zhou, P. (2023) · Figshare · doi:10.6084/m9.figshare.23908871
Additional file 1 of Metformin enhances endogenous neural stem cells proliferation, neuronal differentiation, and inhibits ferroptosis through activating AMPK pathway after spinal cord injury
Xing, C., Liu, S., Wang, L., Ma, H., Zhou, M., Zhong, H., Zhu, S., Wu, Q., & Ning, G. (2024) · Figshare · doi:10.6084/m9.figshare.26757754
Additional file 2 of Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway
Zhang, Y.-L., Liu, F., Li, Z.-B., He, X.-T., Li, X., Wu, R.-X., Sun, H.-H., Ge, S.-H., Chen, F.-M., & An, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20329578
Additional file 1 of Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum
Wang, Y., Yu, F., Zheng, X., Li, J., Zhang, Z., Zhang, Q., Chen, J., He, Y., Yang, H., & Zhou, P. (2023) · Figshare · doi:10.6084/m9.figshare.23908868
Additional file 1 of Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus
Li, T., Providencia, R. A., Mu, N., Yin, Y., Chen, M., Wang, Y., Liu, M., Yu, L., Gu, C., & Ma, H. (2021) · Figshare · doi:10.6084/m9.figshare.13669618
Additional file 7 of Early effects of LPS-induced neuroinflammation on the rat hippocampal glycolytic pathway
Vizuete, A. F. K., Fróes, F. T., Seady, M., Zanotto, C., Bobermin, L. D., Roginski, A. C., Wajner, M., Quincozes‐Santos, A., & Gonçalves, C. A. (2022) · Figshare · doi:10.6084/m9.figshare.21316208
Additional file 4 of Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum
Wang, Y., Yu, F., Zheng, X., Li, J., Zhang, Z., Zhang, Q., Chen, J., He, Y., Yang, H., & Zhou, P. (2023) · Figshare · doi:10.6084/m9.figshare.23908880
Additional file 1 of Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway
Zhang, Y.-L., Liu, F., Li, Z.-B., He, X.-T., Li, X., Wu, R.-X., Sun, H.-H., Ge, S.-H., Chen, F.-M., & An, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20329575
Additional file 3 of Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum
Wang, Y., Yu, F., Zheng, X., Li, J., Zhang, Z., Zhang, Q., Chen, J., He, Y., Yang, H., & Zhou, P. (2023) · Figshare · doi:10.6084/m9.figshare.23908874
Phytochemicals and metabolic disorders: managing diabetes, obesity, and metabolic syndrome
Srinivasa, U. M., Paramasivan, K., & Anitha, R. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26494-8.00004-5
The Relationship between Emotional Maturity and Self-Management in Adolescents with Type 2 Diabetes
Ramineh, N., Mousavi4, M. S., & Asiabi, M. M. (2025) · Pajouhan Scientific Journal · doi:10.32592/psj.23.1.42
Internship and Monograph reports entitled ”Metformin: therapeutic targets and their potential in cancer"
Silva, A. F. M. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Effects of Metformin on Leukemia: Biological Mechanisms, Targets, and Treatment Possibilities
Dana, P., & Deezagi, A. (2025) · Journal of Blood and Cancer · doi:10.61882/ijbc.17.3.35
The Effect of Metformin on Coagulation Profiles in Type II Diabetes Mellitus: A Tertiary Care Hospital of Nepal
Maharjan, S., Bhatt, M., Lamichhane, A., Jha, B. K., Twayana, S., & Nepal, B. (2025) · Grande Medical Journal · doi:10.3126/gmj.v5i2.87573
Comprehensive analysis of autophagy- and glycolysis-related differentially expressed genes involved in chronic inflammation in obese patients.
Yang, S. L., Hudabai, R., & Su, X. (2025) · Investigación Clínica · doi:10.54817/ic.v66n4a04
The role of combined Metformin and pharmaceutical molecules with anti-androgenic properties in the therapy of PCOS in adult women
Antoniou-Tsigkos, A., Καρράς, Γ., Papagianni, M., CHRISTOPOULOS, P. F., Vlahos, N. F., & Mastorakos, G. M. (2025) · Endocrine · doi:10.1007/s12020-025-04527-x
Electroacupuncture at ST25 combined with metformin improves intestinal function via the JAK/STAT pathway in a rat model of diabetes
Qian, X., Pei, K., Jiang, Y., Xu, B., & Wu, W. (2026) · Acupuncture in Medicine · doi:10.1177/09645284251410578
Synergistic Mechanistic Insights into Anti-T2DM Benefits of Lentinula edodes: A Peptide- and Polysaccharide-Based Network Pharmacology and Molecular Docking Study
Ma, H.-K., Meng, L., Shen, L., & Ji, H.-F. (2026) · Foods · doi:10.3390/foods15030453
Anti-obesity potential of Eurycoma longifolia: molecular docking and experimental validation in diet-induced obese rats
Airlangga, D. I., Rahmawati, H. R., Triawanti, & Rahman, M. A. (2026) · Acta Biochimica Indonesiana · doi:10.32889/actabioina.228
Metabolic Reprogramming and DNA Damage Response in Prostate Cancer: Implication for treatment
Simpson, K. E., Li, Z., & Liu, X. (2026) · Serican Journal of Medicine · doi:10.17161/sjm.v3i1.24976
Diabetes mellitus
Freichel, M., & Klinge, A. (2026) · Springer eBooks · doi:10.1007/978-3-662-72738-6_10
Quantitative Computational Validation of Nanoscale Interactions between Drug Molecules and Diabetic Wound-Related Proteins for Drug Discovery
Zhang, Z., Qin, Y., Muthuramalingam, R. P. K., Ding, Y., Chng, W. H., Liu, J., Wu, J., Yeow, C., Kan, M.-Y., & Pastorin, G. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00180
Perspective Chapter: A Critical Overview of Metformin Use from Past to Present
Türk, A. H., & Kılıç, H. C. (2026) · Pharmaceutical science. · doi:10.5772/intechopen.1012223
Identifying high-risk combinations of metformin during COVID-19
Dimnjaković, J., Buble, T., Poljičanin, T., Brborović, H., Brađašević, E., & Brborović, O. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343979
Tissue Iron Predicts Metformin Responsiveness in a Mouse Model and in Humans with Type 2 Diabetes
HARRISON, A. V., Usoh, C. O., SINK, S. T., Jain, S., BERRY-PRICE, H., LORENZO, F., & McClain, D. A. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s580024
Drug-Class-Oriented Pharmacogenomics in Type 2 Diabetes: Implications for Personalised Therapy
x, S., & Natarajan, E. (2026) · International Journal of Science and Research (IJSR) · doi:10.21275/sr26211221734
AK5 suppresses breast cancer progression and modulates anti-PD-L1 efficacy via the miR-182-5p/PD-L1 axis
Sun, G.-S., Li, Y.-H., Li, L., Fan, L.-L., Yang, H., Lu, Q., Liu, Z., Wang, S., & Peng, J.-J. (2026) · iScience · doi:10.1016/j.isci.2026.115260
Holding cancer in line: the role of the electron transport chain in tumor-associated macrophages
Zotta, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1802495
Perioperative anesthesia care for patients with diabetes mellitus: a review of current literature with focus on oral antidiabetic medication
Riesemann, S., Tenge, T., & Roth, S. (2026) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001644
Effet de la metformine sur la production des formes réactives de l'oxygène par les macrophages M2 humains et les cellules épithéliales intestinales cancéreuses HCT116
Nassif, R. (2021) · theses.fr (ABES) · doi:10.70675/25eb5ad3za8e9z4ef0zaf50ze761f2fc5884
Impact de l'insuffisance rénale chronique sur la sévérité des accidents vasculaires cérébraux dans un modèle de souris : rôle de l'adénosine monophosphate-activated protein kinase, AMPK
Grissi, M. (2021) · theses.fr (ABES) · doi:10.70675/bcd240b7z43c2z4dd5z9ed8zae89b2a38dd4
Integrating generative AI and genetic causal inference identifies metformin as a repurposing candidate for normal tension glaucoma
Jiang, J., Hu, D., Zhang, Q., & Lin, Z. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70537
Étude et modulation des mécanismes contrôlant la résolution de la fibrose du tissu adipeux au cours de l’obésité et de la perte de poids
Rebière, C. (2024) · theses.fr (ABES) · doi:10.70675/68c3d6d8zeed7z4d9ez9fb6z6302a8275981
Interaksi antara Herbal dan Antidiabetik Oral pada Penderita Diabetes Melitus: Tinjauan Mekanisme Aksi
Shidiqiyah, N. H., Herlaesa, S. R., Piola, O., Hariadi, N. N. A., Basmalah, N., Putri, M. D., & Hilmi, I. L. (2026) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v9i1.1207
ГІПОГЛІКЕМІЧНА ТА КАРДІОЦИТОПРОТЕКТОРНА ДІЯ МЕТФОРМІНУ, РЕСВЕРАТРОЛУ ТА ЇХ КОМБІНАЦІЇ ЗА ЕКСПЕРИМЕНТАЛЬНОГО ЦУКРОВОГО ДІАБЕТУ
Piliponova, V. V., & Українець, О. (2026) · Перспективи та інновації науки · doi:10.52058/2786-4952-2026-3(61)-2560-2579
The Role of ATP Synthase Subunit e (ATP5I) in Mediating the Metabolic and Antiproliferative Effects of MetforminPreprint
Lefrançois, G., Lavallée, E., Rowell, M., Bourdeau, V., Mohebali, F., Bertomeu, T., Duman, A. M., Nikolova, M., Tyers, M., Gravel, S., et al. (2026) · eLife · doi:10.7554/elife.102680.2
Effectiveness of GLP-1RA vs metformin for diabetes prevention in antipsychotic-treated patients
Liu, T.-H., Lee, C.-H., Liu, C.-Y., Wu, J., Tsai, Y., Kao, P., & Lai, C. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112853
Biotin-tailored self-assembly conjugate nanoplatform via CD47 blockade and macrophage reprogramming for enhanced head and neck squamous cell carcinoma immunotherapy
Ye, Q., Huang, Y., Tian, H., Tingting, Z., Zhou, L., Qin, S., Bentley, G. T., Huang, C., & Xie, K. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.176954
SYNERGISTIC REGULATION OF AMPK-DEPENDENT REDOX HOMEOSTASIS BY METFORMIN AND QUERCETIN IN HIGH-GLUCOSE-CHALLENGED HEPG2 CELLS
Srinivasa, B., Devaraneni, A., Vaheedha, S., & Ramalingam, V. (2026) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2026v19i5.59134
Metformin as a Potential Geroprotective Agent: Mechanisms, Clinical Evidence and Implications for Healthy Aging
Kawalec, P., Bronikowski, K., Ryszkowski, M., Fornal, K., Będkowska-Kuśmierek, N., Zaborowska, S., Pawlak, P., Wojcieszuk, O., Starczewski, Ł., & Babik, A. (2026) · Journal of Education Health and Sport · doi:10.12775/jehs.2026.91.70768
Evaluating the Impact of Social and Environmental Factors on the Use of HHH Medications Using Wastewater-Based Epidemiology in 30 Cities in China
Zhang, R., Zhang, L., Du, P., Zheng, Q., Dang, A. K., Zhang, Y., Ma, K., Fang, Z., Li, X., & Thai, P. K. (2026) · Water · doi:10.3390/w18101175
Reviewer #3 (Public review): The role of ATP synthase subunit e (ATP5I) in mediating the metabolic and antiproliferative effects of metformin in cancer cells
(2026) · eLife · doi:10.7554/elife.102680.3.sa3
Author response: The role of ATP synthase subunit e (ATP5I) in mediating the metabolic and antiproliferative effects of metformin in cancer cells
Lefrançois, G., Lavallée, E., Rowell, M., Bourdeau, V., Mohebali, F., Bertomeu, T., Duman, A. M., Nikolova, M., Tyers, M., Gravel, S., et al. (2026) · eLife · doi:10.7554/elife.102680.3.sa4
Regulatory Effects and Mechanisms of Electromagnetic Low-Energy Shock Wave Therapy on Blood Glucose in Type 2 Diabetic Rats
He, Y., Huo, S., Hao, L., Yue, Z., Jiang, Y., Zhu, J., & Zhou, Z. (2026) · Biology · doi:10.3390/biology15100810
A Prospective Care-Compliant Case Series on Withania Coagulans Monotherapy in Patients with Type 2 Diabetes Mellitus
Nama, P., Panda, S., Sarkar, S., & Taraphdar, A. K. (2026) · International Journal of Ayurveda and Pharma Research · doi:10.47070/ijapr.v14i4.4098
Targeting inflammatory pathways in T2DM: Therapeutic interventions
Ali, S., & Jamous, Y. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33590-7.00003-4
Medication–Meal Timing: An Underrecognized Determinant of Drug Efficacy and Safety
Faisal, H., & Lal, K. C. (2026) · INNOVAPATH · doi:10.63501/qb3ey096
Imeglimin enhances GLUT4-mediated glucose uptake and is more effective than metformin in 3T3-L1 adipocytes
Takahashi, N., Kimura, A. P., Yoshizaki, T., & Ohmura, K. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154193
Metformin Partially Attenuates Simvastatin‐Induced Myotoxic Responses in C2C12 Myotubes Through Metabolic Adaptation
He, C., Wesselink, M., Huijts, J. Y., Zhong, Z., Eggelbusch, M., Jaspers, R. T., & Wüst, R. C. I. (2026) · The FASEB Journal · doi:10.1096/fj.202600077rrr
Copper dysregulation in cardiometabolic disease: copper deficiency versus cuproptosis
Kawuribi, V., Tauro, C., Rukonge, P. A., Mwanza, J. C., Madadi, M. M., & Adu‐Amankwaah, J. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02390-3
Supra-additive neuroprotective effects of berberine–metformin combination in diabetic encephalopathy: Chou–Talalay synergy quantification, AMPK–Nrf2 axis modulation, and pharmacokinetic verification
Filfilan, W. M., & El‐Beeh, M. E. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01910-z
НЕЙРОПРОТЕКТОРНЫЕ ФУНКЦИИ МЕТФОРМИНА (ОБЗОР ЛИТЕРАТУРЫ)
Гридасова, Е. И., Плешкова, В. С., Чичкан, А. С., & Смирнова, П. Н. (2026) · Military and tactical medicine Emergency medicine · doi:10.55359/2782-3296.2026.81.44.009
Ethanolamine phosphate phospholyase in NAFLD: Emerging mechanisms, pathways, and therapeutic opportunities
Du, J., & Mu, Y. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156615
Development and Internal Validation of a Nomogram for Predicting 28-Day Mortality in Elderly Hip Fracture Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study Based on MIMIC-IVPreprint
Zhao, Y., Li, J., & Cui, X. (2026) · Research Square · doi:10.21203/rs.3.rs-10016112/v1
Comparative Evaluation of Metformin, PVP-Coated Silver Nanoparticles, and Metformin-Loaded PVP-Coated Silver Nanoparticles on Metabolic Dysfunction, Oxidative Stress, and Organ Injury in Experimental Diabetes
El-Hak, H. N. G., Taha, N. A., Hussein, A. A., Saad, E. M., & El‐Shenawy, N. S. (2026) · BioNanoScience · doi:10.1007/s12668-026-02720-4
Structural characterization and systemic hypoglycemic effects of a new high-molecular-weight α-glucan from Grifola frondosa
Zhong, W., Wang, J., Yu, D., Huang, L., Tian, H., Ruan, Q., Li, X., Liu, Y., Yong, T., Chen, S., et al. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.125672
Assessment of the Antidiabetic and Antihyperlipidemic activity of Solanum torvum Ethanolic Extract in HepG2 Cells
Male, C. K. V. L. S. N. A., & Shakya, R. (2026) · PAIN JOINTS SPINE · doi:10.1922/pjs.16.7s.2026.912
Metformin modulates hepatitis B via metabolic pathways: A Mendelian randomization study of mediation effects
Gao, F., 冯鲜妮, Sun, Q., & He, W. (2026) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2026.06.023
Fructose-1,6-bisphosphatase as a therapeutic target for type 2 diabetes: from molecular mechanisms to clinical translation
Joshi, P., Mazumder, A., Pentela, B., & Debnath, A. (2026) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2026.2706204
Defined Natural Products as Adjunctive Therapies: Evidence-Gated Polypharmacology Across Molecular Targets, Human Exposure, Clinical Signals, and Safety Boundaries
Seo, Y., & Woo, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167111
Glycation at the Gate: A Brain Endothelial Glycocalyx Model and Therapeutic Roadmap for Alzheimer’s Disease
Tarawneh, R. (2026) · Biomedicines · doi:10.3390/biomedicines14081794
Effect of Metformin on Progression from Prediabetes to Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Hartany, L. O. A., Alghorab, M. A., Alhomieed, M. F., Albalawi, R. S., Almowallad, A. A., Alsharif, A., Amin, A. S., Alamri, S. F., Aljabal, T. K., & Alkthiry, A. (2026) · Diabetology · doi:10.3390/diabetology7080156
Gut Microbiota in Type 2 Diabetes and Metabolic Disorders: Sources of Heterogeneity and Ways to Resolve Contradictions in Research
Nesterova, E. Y., Gladkikh, M. I., Burakova, I. Y., Korneeva, O. S., Dmitrievna, M. P., & Syromyatnikov, M. (2026) · Diabetology · doi:10.3390/diabetology7080153
From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals
Teofilović, B. D., Trkulja, J., Grujić-Letić, N. N., Gligorić, E. I., Baletic, D., Tomić, L., Mesarović, A., & Rašković, A. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2727202
Additive effects of metformin on glucose homeostasis after metabolic-bariatric surgery in nonobese insulin-deficient diabetic rats
Hirlemann, M., Garmon, M., Ribeiro‐Parenti, L., Bailbé, D., Willemetz, A., Shahrour, H. E.-J., Movassat, J., Carette, C., & Gall, M. L. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00077.2026
Agaricus bisporus chitosan modification improves the stability, intestinal retention, and hypoglycemic performance of metformin-encapsulated liposomes
Chen, Y., Zhang, J., Wang, X., Zhang, M., You, L., & Hileuskaya, K. S. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154372
Relationship Between Diabetes Mellitus and Urinary Tract Infections: Pathogenesis, Risk Factors, and Management Strategies
Raheem, I. T., Matshar, E. K., Sahib, K. A., Atyah, B. S., & AlKareem, D. A. (2026) · Journal of Biotechnology Research Center · doi:10.24126/jobrc.2026.20.2.1018
Disease-Oriented Drug Repurposing in Lung Cancer: Targeting Metabolic Plasticity and Therapy Resistance
Alinejad, T., Alinejad, Z., Ghadirli, R. N., Modarresi, S., & Bhassu, S. (2026) · Pharmaceutical science. · doi:10.5772/intechopen.1016991
Genetic Variants Involved in Metformin Pharmacokinetics in the Chilean Population
Miranda, J. P., Alberti, G., Pereira, A., Gana, J. C., & Santos, J. L. (2026) · Genes · doi:10.3390/genes17091114

Authors: Foretz, M., Guigas, B., & Viollet, B.
Affiliations: Centre National de la Recherche Scientifique (FR)
Leiden University Medical Center (NL)
ORCID: Foretz, Marc
Guigas, Bruno
Viollet, Benoit
Venue: Nature Reviews Endocrinology
Publisher: Springer Science and Business Media LLC
Published: 2019-08-22
Volume: 15
Issue: 10
Pages: 569-589
ISSN: 1759-5029 (ISSN-L)
1759-5037
DOI: 10.1038/s41574-019-0242-2
OpenAlex: W2969928163
Cited by: 686
References: 261
Citations by year: 2026: 80 · 2025: 104 · 2024: 92 · 2023: 122 · 2022: 113 · 2021: 102 · 2020: 68 · 2019: 5
FWCI: 6.34
Type: journal article
Language: en
Open access: green
inserm.hal.science
Licence: other-oa
www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Endocrinology (publishedVersion)
PubMed (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
HAL (submittedVersion, other-oa)
Leiden Repository (Leiden University) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords: metformin, type 2 diabetes, glucoregulation, hepatic glucose production, gluconeogenesis, AMPK, mitochondrial complex I inhibition, hepatic insulin sensitivity, adenylate cyclase inhibition, FBP1, glycerol-3-phosphate dehydrogenase, redox state, meta-inflammation, obesity, gut microbiota, glucagon-like peptide-1, bile acids
MeSH terms: Gastrointestinal Microbiome, Animals, Diabetes Mellitus, Type 2, Electron Transport, Glucose, Humans, Hypoglycemic Agents, Metformin, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks